Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: a new challenge in cardio-oncology

Intern Emerg Med. 2012 Oct;7(5):399-401. doi: 10.1007/s11739-012-0845-2. Epub 2012 Sep 2.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Breast Neoplasms / drug therapy*
  • Female
  • Heart Diseases / chemically induced*
  • Humans
  • Renal Insufficiency / complications*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal, Humanized
  • Trastuzumab